Substance Abuse Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type (Drug Abuse, Alcohol, Tobacco/Nicotine, Others); By End-Use; By Region; Segment Forecast, 2023 - 2032
- Published Date:May-2023
- Pages: 118
- Format: PDF
- Report ID: PM3217
- Base Year: 2022
- Historical Data: 2019-2021
Report Outlook
The global substance abuse treatment market was valued at USD 10.14 billion in 2022 and is expected to grow at a CAGR of 8.1% during the forecast period. The rise in illicit drug use among adults and excessive consumption of tobacco and alcohol is driving growth in the global substance abuse treatment market. Non-profit organizations and national governments are introducing various awareness campaigns through media such as television, newspapers, and magazines to increase awareness about substance abuse treatment. This is expected to result in more patients seeking treatment, fueling market growth during the forecast period.
Know more about this report: Request for sample pages
The excessive and self-destructive consumption of habit-forming substances or drugs can lead to addiction, dependence, severe physical harm, mental damage, and even death. This has prompted an increased awareness among patients, higher rates of seeking treatment, greater government involvement, and incentives to reduce substance use worldwide, all contributing to the substance abuse treatment market growth.
Furthermore, the widespread availability of drugs and other substances has made substance abuse a major concern in today's world. Not only does substance abuse have a negative impact on the individual involved, but it can also have a ripple effect on society as a whole, hindering its growth and progress. The abuse of drugs and alcohol is a significant contributor to social issues such as child abuse, increased crime rates, child neglect, hospitalizations, and a strain on public healthcare funds. For instance, according to the National Institute of Drug Abuse, over 85% of the prison population has a history of substance abuse or is incarcerated for drug-related offenses.
The COVID-19 pandemic has significantly impacted the Market. The pandemic has caused an increase in substance abuse cases due to heightened stress and anxiety levels while also making it challenging for individuals to access treatment due to movement restrictions and social distancing measures. Consequently, many treatment centers have adapted their services by offering telemedicine and virtual treatment options. Despite these challenges, the pandemic has also created new opportunities for the Market. Governments worldwide are allocating funds to expand treatment services and increase public-private partnerships to provide accessible substance abuse treatment to those in need.
Know more about this report: Request for sample pages
Industry Dynamics
Growth Drivers
Increased awareness and understanding of substance abuse and addiction drive the market. This has led to more people seeking treatment, thanks to public health campaigns, education programs, and media coverage highlighting the negative impact of substance abuse on individuals, families, and society. As more people become aware of the dangers of substance abuse, the demand for substance abuse treatment continues to grow.
Moreover, government initiatives and policies to reduce substance abuse have also contributed to the market's growth. Governments worldwide have introduced regulations and procedures to reduce the availability and use of addictive substances and provide funding for treatment programs and services. With the support of government bodies, the market has seen significant growth, making it easier for people to access treatment and support services.
For instance, the World Health Organization (WHO) celebrates World No Tobacco Day on May 31st each year to raise awareness of the health risks associated with tobacco use. Moreover, in June 2021, DC Health launched MyRecoveryDC, a public education campaign to provide access to treatment and recovery services for substance abuse.
Furthermore, advancements in medical technology and treatment methods have improved the efficacy and accessibility of substance abuse treatment. Innovative medications, therapies, and digital tools have made accessing and receiving effective treatment easier for individuals. With the growing number of treatment options available, the market is expected to continue growing in the coming years.
Report Segmentation
The market is primarily segmented based on treatment type, end-use, and region.
|
By Treatment Type |
By End-Use |
By Region |
|
|
|
Know more about this report: Request for sample pages
The drug abuse segment anticipated to dominate the market
The drug abuse segment is anticipated to dominate the global market within the forecast period. This sector provides medical treatment for compulsive behavior and habits involving excessive and self-destructive drug or substance use, leading to addiction or dependency. Drug abuse can cause significant physiological harm, including heart, kidney, and liver damage, as well as psychological suffering, such as abnormal behavior patterns, hallucinations, and memory loss. The increasing use of illicit substances/prescription medications, a surge in fatalities from excessive prescription drug use, and increased research and development by leading pharmaceutical companies throughout the projection period are among the factors driving the demand for drug addiction therapy.
The alcohol segment is predicted to exhibit the fastest growth rate during the forecast period. Consumption of alcohol is widely accepted socially and easily available, leading to high consumption of alcohol worldwide, which shows the increase in the prevalence of alcohol abuse treatment. Additionally, alcohol addiction treatment is expected to experience a substantial increase in demand over the same period.
The hospitals’ segment held the largest market share
The hospitals segment held the largest market share. The dominance of this segment is due to social stigmatization leading to delayed detection and apprehension among patients to avail treatment, resulting in severe cases of addiction that require hospitalization to provide the necessary addiction treatments.
Moreover, individuals with prolonged substance abuse tend to develop other health conditions such as cardiovascular disease, stroke, cancer, HIV/AIDS, Hepatitis B and C, lung disease, and mental disorders. As primary treatment centers, hospitals offer treatment for both substance abuse and the associated health conditions, driving the growth of this segment.
North America is anticipated to grow at the highest CAGR in market
North America is expected to grow at the highest CAGR over the forecast period due to the rising prevalence of substance abuse disorders, increasing awareness of the importance of seeking treatment, and growing government initiatives and insurance coverage for addiction treatment. The North American market offers services and therapies to individuals suffering from addiction, including detoxification, medication-assisted treatment, and counseling, with alcohol and opioid addiction prevalent in the region.
However, Asia Pacific region is projected to experience the fastest growth during the forecast period. This can be attributed to the expanding presence of major players in Asian countries, along with the development of healthcare infrastructure and supportive government initiatives aimed at promoting the adoption of treatment for nicotine, alcohol, and drug addiction. Furthermore, the increasing prevalence of alcohol, tobacco, and opioid addiction in Asian countries is expected to boost the market growth in the region.
Competitive Insight
Some of the major players operating in the global substance abuse treatment market include INSYS Therapeutics, Teva Pharmaceutical, Sun Pharma, Glenmark, Sanofi Aventis, Sterinova, Apotex, BioCorRx, Opiant Technologies, Accord Healthcare, Mylan Laboratories, Cipla, LFB Group, Lupin, Amphastar Pharmaceuticals, and Sanquin.
Recent Developments
- In November 2022, Indivior PLC and Opiant Pharmaceuticals agreed to fortify and extend Indivior's standing in the addiction treatment market.
- In June 2021, INDIVIOR PLC and AELIS FARMA partnered and announced an option-license agreement to tackle the considerable consequences of cannabis use disorders (CUD), which include cannabis-induced psychosis (CIP).
Substance Abuse Treatment Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2023 |
USD 10.89 billion |
|
Revenue forecast in 2032 |
USD 22.01 billion |
|
CAGR |
8.1% from 2023 – 2032 |
|
Base year |
2022 |
|
Historical data |
2019 – 2021 |
|
Forecast period |
2023 – 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2023 to 2032 |
|
Segments Covered |
By Treatment Type, By End-Use, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Key Companies |
INSYS Therapeutics, Teva Pharmaceutical, Sun Pharma, Glenmark, Sanofi Aventis, Sterinova, Apotex, BioCorRx, Opiant Technologies, Accord Healthcare, Mylan Laboratories, Cipla, LFB Group, Lupin, Amphastar Pharmaceuticals, and Sanquin. |
FAQ's
The global substance abuse treatment market size is expected to reach USD 22.01 million by 2032.
Key players in the substance abuse treatment market are INSYS Therapeutics, Teva Pharmaceutical, Sun Pharma, Glenmark, Sanofi Aventis, Sterinova, Apotex, BioCorRx.
North America contribute notably towards the global substance abuse treatment market.
The global substance abuse treatment market expected to grow at a CAGR of 8.1% during the forecast period.
The substance abuse treatment market report covering key segments are treatment type, end-use, and region.
